PL103556B1 - Sposob wytwarzania nowych pochodnych chinazolonu - Google Patents
Sposob wytwarzania nowych pochodnych chinazolonu Download PDFInfo
- Publication number
- PL103556B1 PL103556B1 PL1976201603A PL20160376A PL103556B1 PL 103556 B1 PL103556 B1 PL 103556B1 PL 1976201603 A PL1976201603 A PL 1976201603A PL 20160376 A PL20160376 A PL 20160376A PL 103556 B1 PL103556 B1 PL 103556B1
- Authority
- PL
- Poland
- Prior art keywords
- group
- compounds
- chinazolone
- quinazoline
- new derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Description
Przedmiotem wynalazku jest sposób wytwarza¬ nia nowych pochodnych chlinazolonai o wzorze Ogólnym 1, w którym A oznacza grupe —CH = =CH—, —GH—=,N— i -^S—, Ri oznacza atom wodoru, grupe aminowa lub karboksylowa lub do- kondensowany pierscien benzenowy, R2 oznacza grupe karboksylowa lub grupe —COR4, przy czym R4 oznacza alkoksylowa o 1—4 atomach wegla, grupe aminowa lub hydroksyloaimiinowa lub tetra- zolilo—5—aminowa, przy czym R2 znajduje sie w (pozycji 2 lub 3. Zwiazki o wzorze 1 moga wystepowac w posta¬ ci wolnych zwiazków, a równiez w postaci soli z zasadami lub kwasami. A oznacza zwlaszcza —S—, przede wszystkim jednak grupe —CH=CH—. Wedlug wynalazku no¬ we zwiazki wytwarza sie przez reakcje zwiazku o wzorze 2, w którym Q oznacza Ri lub grupe GOCI, R ma znaczenie takie jak R2 lub oznacza grupe 1OO1CI i przynajmniej jedna iz grup Q i R oznacza GOCI, ze zwiazkiem o wzorze HZ, w któ¬ rym Z oznacza grupe —CH, —O— /Ci—C4/—alki¬ lowa, NH2, —NH2 —-NHOH lub grupe o wzorze 3, o ile Q stanowi Ri ii —OH, o ile Q oznacza grupe —GOCI, w temperaturze od 0 wrzenia stosowanej mieszaniny reakcyjnej. W definicji produktu koncowego Ri oznacza atoim wodoru, dokondensowiany pierscien benzeno¬ wy, grupe aminowa lub karboksylowa. Z tych grup mozna otrzymac z grupy —GOCI tylko grupe kar¬ boksylowa ^COCl + H — OH - COOH + HC1, tutaj wiec Z musi oznaczac grupe —OH, gdyz HZ musi stanowic wode. Gdy R oznacza grupe —GOCI, wówczas z gru¬ py tej oprócz COOH powstaja równiez rózne po¬ chodne. Na tym jest dokladnie oparta definicja Z. Naturalnie, gdy Q i R oznaczaja GOCI, HZ moze stanowic .tylko wode /HOH/, poniewaz z Q moga jeszcze powstawac równiez inne grupy (to znaczy pochodne grupy karboksylowej) niz COOH. W tym przypadku sposób prowadzi wiazaco tylko do zwiaz¬ ków w których Ri=R2=COCH. Gdy Q od razu ma znaczenie takie jak Ri, reak¬ cja z HZ nie zachodzi. Otrzymane zwiazki nastep¬ nie ewentualnie przeprowadza sie w sole addy¬ cyjne z kwasami, lub o ile zawieraja grupy karbo¬ ksylowe, równiez w sole z organicznymi lub nie¬ organicznymi zasadami. Z otrzymanych pierwot¬ nie soli ewentualnie uwalnia sie wolne zwiazki o wzorze 1. Produkty wyjsciowe otrzymuje sie znanymi jako takie sposobami. Zwiazki wyjsciowe wszystkie za¬ wieraja grupe GOCI. Poniewaz grupa ta jest bar¬ dzo reaktywna, zwiazki wyjsciowe nie moga znaj¬ dowac zastosowania w celach terapeutycznych, gdyz podczas hydrolizy w organizmie powstaje HG1. Otrzymywane sposoibem wedlug wynalazku no- 103 5563 103 556 4 we zwiazki znajduja zastosowanie w terapeutyce lub moga sluzyc jako produkty posrednie do wyt¬ warzania srodków leczniczych, przy czym nalezy podkreslic ich dzialanie przeciwalergiczne. Leki te mozna wykorzystac w profilaktyce i leczeniu scho¬ rzen alergicznych, .takich jak .-astma lub goraczka sienna, 'zapalenie ispojówek, pokrzytwka, egzeima, uczuleniowe zapalenie skóry. Zwiazki gte wykazuja ponadto dzialanie 'bronchodylatoryjne, i rozszerza¬ jace naczynia. Przy najwazniejszym stosowaniu, a mianowicie w profilaktyce astmy, nalezy wy¬ mienic jako zalety w sitosiunfcu ido produktu han¬ dlowego kwasu kromoglicyinowego, dluzszy okres dzialania i przede wszystkim dzialanie doustne. Znanym produktem handlowym o podobnym dzialaniu jest Na-^, Cromoglycat (IntalR', zwiazek o wzorze A). Wczesniej znanym byl zwiazek o wzo¬ rze B omówiony w holenderekim opasie patento¬ wym nr 6 414 717. Rózne .zwiazki poddano badaniom na test PCA (hamowanie pasywnej skóry anafilaksji) na ich dzialanie przeciwalergiczne. Okazalo sie przy tym, ze zwiazki otrzymywane sposobem wedlug wyna¬ lazku w przeciwienstwie do nieczynnych doustnie zwiazków porównawczych wykazuja dobre dzia¬ lanie przy stosowaniu doustnie. * Tak wiec przy stosowaniu kwasu 11—keto—11— —H—pirydo /2,1—b/—chinazolino—2—korboksylo- wego doustnie szczurom LD5o wynosi 2,7 mg/kg przy (bardzo malej toksycznosci (LD50 dla myszy, doustnie: 2000 mg/kg). Równiez inne otrzymywane sposobem wedlug wynalazku substancje czynne wykazuja dobre dzia¬ lanie przy stosowaniu doustnym, jak wskazuja da¬ ne przedstawione w nizej podanej tablicy. I; ester etylowy kwasu 12-keto-12-H-chino- /2,1-b/chinozalino-10-karTboksylowego II: kwas 13-keto-13-H-ibenzo/g/npirydo /2,W- -chinazolino-10-karfooksylowy III: kwas ll-keto-ll-H-2-metoksypiirydo /2,1-b/- -chinazolino-8^karlboksylowy IV: kwas 11-keto-ll-H-pirydo /2,l-b/-chinazolino- -34saribolksylowy V: 11-keto-ll-H-pirydo /2,l-b/-chinazolino-2-kar- boksyamid Tablica Substancja I II III IV V Dawka 100 mg/kg mg/kg 100 mg/kg 100 mg/kg 100 mg/kg Zachamowanie PCA 70% 100% 50% 76% 48% Przyklad L Ester metylowy kwasu 11-keto- -11-H-pirydo /2,1-b/-chinazolino-2-karboksylowego o wzorze 4. 6,2 g chlorowodorku kwasu 11-keto- 11-H^pirydo /2,Hb/-chinaiZOlino-2-karboksylowego w 10-krotnej ilosci chlorku tionylu ogrzewa sie do wrzenia pod chlodnica zwrotna przez 1 godzine. Nierozpuszczalny chlorek kwasu karboksylowego odciaga sie i w 10-20-krotnej ilosci metanolu ogrze¬ wa sie do wrzenia pod chlodnica zwrotna az do calkowitego rozpuszczenia. Po oziebieniu wykrysta- lizowuje chlorowodorek eistru metylowego kwa¬ su 11-keto-ll-H-pirydo /2,l-ib/-chinazolino-2-kar- boksylowego z 1 molem metanolu {temperatura rozkladu: 254 PL PL PL PL PL
Claims (1)
1.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2557425A DE2557425C2 (de) | 1975-12-19 | 1975-12-19 | 11-Oxo-11-H-pyrido[2,1-b]-chinazolin-2-carbonsäure und ihre Salze, Verfahren zu ihrer Herstellung und Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL103556B1 true PL103556B1 (pl) | 1979-06-30 |
Family
ID=5964943
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1976194519A PL101141B1 (pl) | 1975-12-19 | 1976-12-18 | Sposob wytwarzania nowych pochodnych chinazolonu |
| PL1976209362A PL110780B1 (en) | 1975-12-19 | 1976-12-18 | Method of producing new derivatives of quinazolone |
| PL1976201604A PL102308B1 (pl) | 1975-12-19 | 1976-12-18 | A method of producing new derivatives of quinazolone |
| PL1976209361A PL111422B1 (en) | 1975-12-19 | 1976-12-18 | Process for the preparation of novel derivatives of quinazolone |
| PL1976201603A PL103556B1 (pl) | 1975-12-19 | 1976-12-18 | Sposob wytwarzania nowych pochodnych chinazolonu |
Family Applications Before (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1976194519A PL101141B1 (pl) | 1975-12-19 | 1976-12-18 | Sposob wytwarzania nowych pochodnych chinazolonu |
| PL1976209362A PL110780B1 (en) | 1975-12-19 | 1976-12-18 | Method of producing new derivatives of quinazolone |
| PL1976201604A PL102308B1 (pl) | 1975-12-19 | 1976-12-18 | A method of producing new derivatives of quinazolone |
| PL1976209361A PL111422B1 (en) | 1975-12-19 | 1976-12-18 | Process for the preparation of novel derivatives of quinazolone |
Country Status (36)
| Country | Link |
|---|---|
| US (2) | US4083980A (pl) |
| JP (1) | JPS5831350B2 (pl) |
| AT (1) | AT352736B (pl) |
| AU (1) | AU513469B2 (pl) |
| BE (1) | BE849542A (pl) |
| BG (3) | BG25093A3 (pl) |
| CA (1) | CA1199914A (pl) |
| CH (4) | CH627754A5 (pl) |
| CS (1) | CS198222B2 (pl) |
| DD (1) | DD128812A5 (pl) |
| DE (1) | DE2557425C2 (pl) |
| DK (1) | DK149107C (pl) |
| ES (3) | ES454405A1 (pl) |
| FI (1) | FI64159C (pl) |
| FR (1) | FR2335229A1 (pl) |
| GB (1) | GB1572707A (pl) |
| GR (1) | GR62109B (pl) |
| HK (1) | HK12984A (pl) |
| HU (1) | HU172929B (pl) |
| IE (1) | IE45256B1 (pl) |
| IL (1) | IL51124A (pl) |
| LU (1) | LU76417A1 (pl) |
| MX (1) | MX4488E (pl) |
| MY (1) | MY8500078A (pl) |
| NL (1) | NL182535C (pl) |
| NO (1) | NO147450C (pl) |
| NZ (1) | NZ182915A (pl) |
| PH (1) | PH16310A (pl) |
| PL (5) | PL101141B1 (pl) |
| PT (1) | PT65981A (pl) |
| RO (3) | RO69411A (pl) |
| SE (1) | SE431456B (pl) |
| SG (1) | SG55483G (pl) |
| SU (4) | SU645571A3 (pl) |
| YU (2) | YU39048B (pl) |
| ZA (1) | ZA767490B (pl) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4337255A (en) * | 1977-07-29 | 1982-06-29 | E. R. Squibb & Sons, Inc. | Pyrazolo[1,5-c]quinazoline derivatives and related compounds |
| HU182009B (en) * | 1977-08-19 | 1983-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing substituted pirido-square bracket-1,2-a-square bracket closed-pyrimidines, pyrrolo-square bracket-1,2-a-square bracket closed-pyrimidines |
| DE2739020A1 (de) | 1977-08-26 | 1979-03-01 | Schering Ag | Pyrido eckige klammer auf 2,1-b eckige klammer zu -chinazolinon-derivate, ihre herstellung und verwendung |
| US4348396A (en) * | 1978-01-23 | 1982-09-07 | Hoffmann-La Roche Inc. | Substituted 11-oxo-11H-pyrido[2,1-b]quinazolines and method of inhibiting allergic reactions with them |
| US4168380A (en) * | 1978-04-21 | 1979-09-18 | Hoffmann-La Roche Inc. | 7-Methoxy-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid |
| US4223031A (en) * | 1978-05-05 | 1980-09-16 | Mead Johnson & Company | Azolopyrimidinones |
| US4491587A (en) * | 1978-05-05 | 1985-01-01 | Mead Johnson & Company | Tetrazole derivatives |
| US4209620A (en) * | 1978-06-19 | 1980-06-24 | Bristol-Myers Company | Substituted 3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives having antiallergy activity |
| DE2845766A1 (de) * | 1978-10-18 | 1980-04-30 | Schering Ag | Pyrido eckige klammer auf 2,1-b eckige klammer zu -chinazolinon-derivate, ihre herstellung und verwendung |
| DE3065963D1 (en) * | 1979-01-24 | 1984-02-02 | Warner Lambert Co | Pyrazolo (5,1-b) quinazolin-9(4h)-one derivatives, process for their preparation and pharmaceutical compositions containing them |
| US4282360A (en) * | 1979-10-12 | 1981-08-04 | Hoffmann-La Roche Inc. | 7-Methylthio or methylsulfinyl-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid |
| US4302585A (en) | 1980-12-22 | 1981-11-24 | American Home Products Corporation | 3-Hydroxy-3-substituted phenylthiazolo[2,3-b]quinazoline-2-alkanoic acids and their lactones |
| US4395549A (en) | 1981-10-02 | 1983-07-26 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. | 6-Hydrazono-pyrido[2,1-b] quinazoline-11 ones |
| DE3142727A1 (de) * | 1981-10-28 | 1983-05-05 | Basf Ag, 6700 Ludwigshafen | Thiazolo (2,3-b)-chinazolone, verfahren zu ihrer herstellung und ihre verwendung zur beeinflussung des pflanzenwachstums |
| DE3142728A1 (de) * | 1981-10-28 | 1983-05-05 | Basf Ag, 6700 Ludwigshafen | Herbizide, enthaltend thiazolo(2,3-b)-chinazolone als wirkstoffe, und ihre verwendung zur beeinflussung des pflanzenwachstums |
| ES8406476A1 (es) * | 1982-04-29 | 1984-07-01 | Erba Farmitalia | Procedimiento para preparar derivados cicloalifaticos condensados de pirido(1,2-a)pirimidinas sustituidas. |
| US4551460A (en) * | 1982-05-10 | 1985-11-05 | Hoffmann-La Roche Inc. | Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis |
| US4455312A (en) * | 1982-08-19 | 1984-06-19 | Portnyagina Vera A | 2-(o-Carboxyphenylamino)-6H-pyrimido(2,1-b)-quinazolone-6 and derivatives thereof, and application as antiphlogistics |
| DE3300477A1 (de) * | 1983-01-08 | 1984-07-12 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue heterocyclische verbindungen, ihre herstellung und verwendung |
| GB8300728D0 (en) * | 1983-01-12 | 1983-02-16 | Erba Farmitalia | Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives |
| EP0142057A3 (en) * | 1983-11-04 | 1988-03-30 | F. Hoffmann-La Roche Ag | Thiazoloquinazoline derivatives, their preparation and pharmaceutical compositions containing same |
| US4588812A (en) * | 1984-05-30 | 1986-05-13 | Pennwalt Corporation | Substituted 2,3-dihydro-5H-thiazolo[2,3,-b]quinazoline derivatives |
| US4738964A (en) * | 1984-05-30 | 1988-04-19 | Pennwalt Corporation | Method of suppressing the immune system comprising administering 5H-thiazolo[2,3-b]quinazoline-3(2H)-one |
| DE3634532A1 (de) * | 1986-10-10 | 1988-04-14 | Basf Ag | Verfahren zur herstellung von thiazolo-(2,3-b)chinazolonen |
| DE3704203A1 (de) * | 1987-02-11 | 1988-08-25 | Boehringer Ingelheim Kg | Verwendung von oxochinazolinderivaten bei der behandlung der hyperurikaemie |
| US4904667A (en) * | 1989-02-24 | 1990-02-27 | Ortho Pharmaceutical Corporation | 1H-1,2,4-thiadiazolo(3,4-b)quinazolin-5-one-2,2-dioxides, and a method for increasing the cardiac output of a mammal with them |
| US6800651B2 (en) | 2000-02-03 | 2004-10-05 | Eli Lilly And Company | Potentiators of glutamate receptors |
| US8946223B2 (en) | 2010-04-12 | 2015-02-03 | Millennium Pharmaceuticals, Inc. | Substituted hydroxamic acids and uses thereof |
| WO2012054332A1 (en) | 2010-10-18 | 2012-04-26 | Millennium Pharmaceuticals, Inc. | Substituted hydroxamic acids and uses thereof |
| ES2770123T3 (es) | 2015-02-02 | 2020-06-30 | Forma Therapeutics Inc | Acidos 3-alquil-4-amido-bicíclicos [4,5,0]hidroxámicos como inhibidores de HDAC |
| TW201636329A (zh) | 2015-02-02 | 2016-10-16 | 佛瑪治療公司 | 作為hdac抑制劑之雙環[4,6,0]異羥肟酸 |
| EP3472131B1 (en) | 2016-06-17 | 2020-02-19 | Forma Therapeutics, Inc. | 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1242863A (en) * | 1968-05-10 | 1971-08-18 | Pharmacia As | 2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF |
| US3598823A (en) * | 1969-05-28 | 1971-08-10 | Sandoz Ag | Tricyclic quinazolinones |
| US3833588A (en) * | 1972-04-25 | 1974-09-03 | Sandoz Ag | Unsaturated-substituted tricyclic quinazolinones |
| JPS5752352B2 (pl) * | 1974-02-28 | 1982-11-06 | ||
| US4012387A (en) * | 1975-09-18 | 1977-03-15 | Warner-Lambert Company | Benzo-[g]pyrido[2,1-b]quinazolinones |
| US4033961A (en) * | 1975-10-07 | 1977-07-05 | Warner-Lambert Company | Pyrido[2-1-b]quinazolin-ones and their methods of preparation |
| US4142049A (en) * | 1976-10-18 | 1979-02-27 | Warner-Lambert Company | Benzo[g]pyrido[2,1-b]quinazolinones |
| US4066767A (en) * | 1976-11-01 | 1978-01-03 | Warner-Lambert Company | 8-(1H-Tetrazol-5-yl)-11H-pyrido[2,1-b]quinazolin-11-ones and method of treating bronchial asthma using them |
| DE2812585A1 (de) * | 1977-03-24 | 1978-09-28 | Hoffmann La Roche | Chinazolin-derivate |
| DE2739020A1 (de) * | 1977-08-26 | 1979-03-01 | Schering Ag | Pyrido eckige klammer auf 2,1-b eckige klammer zu -chinazolinon-derivate, ihre herstellung und verwendung |
| US4168380A (en) * | 1978-04-21 | 1979-09-18 | Hoffmann-La Roche Inc. | 7-Methoxy-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid |
-
1975
- 1975-12-19 DE DE2557425A patent/DE2557425C2/de not_active Expired
-
1976
- 1976-11-30 AT AT883976A patent/AT352736B/de not_active IP Right Cessation
- 1976-12-02 FI FI763469A patent/FI64159C/fi not_active IP Right Cessation
- 1976-12-07 GR GR52342A patent/GR62109B/el unknown
- 1976-12-14 CS CS768172A patent/CS198222B2/cs unknown
- 1976-12-15 RO RO7688735A patent/RO69411A/ro unknown
- 1976-12-15 RO RO7695226A patent/RO75248A/ro unknown
- 1976-12-15 US US05/750,725 patent/US4083980A/en not_active Expired - Lifetime
- 1976-12-15 RO RO7695227A patent/RO75734A/ro unknown
- 1976-12-16 SU SU762429454A patent/SU645571A3/ru active
- 1976-12-16 CH CH284581A patent/CH627754A5/de not_active IP Right Cessation
- 1976-12-16 DK DK567376A patent/DK149107C/da not_active IP Right Cessation
- 1976-12-16 CH CH1583776A patent/CH625522A5/de not_active IP Right Cessation
- 1976-12-16 DD DD7600196412A patent/DD128812A5/xx unknown
- 1976-12-17 HU HU76BO00001645A patent/HU172929B/hu not_active IP Right Cessation
- 1976-12-17 AU AU20695/76A patent/AU513469B2/en not_active Expired
- 1976-12-17 BE BE173384A patent/BE849542A/xx not_active IP Right Cessation
- 1976-12-17 ZA ZA00767490A patent/ZA767490B/xx unknown
- 1976-12-17 FR FR7638135A patent/FR2335229A1/fr active Granted
- 1976-12-17 NO NO764303A patent/NO147450C/no unknown
- 1976-12-17 BG BG035902A patent/BG25093A3/xx unknown
- 1976-12-17 GB GB52857/76A patent/GB1572707A/en not_active Expired
- 1976-12-17 SE SE7614258A patent/SE431456B/xx not_active IP Right Cessation
- 1976-12-17 BG BG035901A patent/BG24673A3/xx unknown
- 1976-12-17 BG BG034932A patent/BG25092A3/xx unknown
- 1976-12-17 NL NLAANVRAGE7614013,A patent/NL182535C/xx not_active IP Right Cessation
- 1976-12-17 YU YU03082/76A patent/YU39048B/xx unknown
- 1976-12-17 CA CA000268164A patent/CA1199914A/en not_active Expired
- 1976-12-17 IE IE2777/76A patent/IE45256B1/en not_active IP Right Cessation
- 1976-12-17 NZ NZ182915A patent/NZ182915A/xx unknown
- 1976-12-17 MX MX765246U patent/MX4488E/es unknown
- 1976-12-17 JP JP51151051A patent/JPS5831350B2/ja not_active Expired
- 1976-12-17 IL IL51124A patent/IL51124A/xx unknown
- 1976-12-17 LU LU76417A patent/LU76417A1/xx unknown
- 1976-12-17 PT PT65981A patent/PT65981A/pt unknown
- 1976-12-18 ES ES454405A patent/ES454405A1/es not_active Expired
- 1976-12-18 PL PL1976194519A patent/PL101141B1/pl unknown
- 1976-12-18 PL PL1976209362A patent/PL110780B1/pl unknown
- 1976-12-18 PL PL1976201604A patent/PL102308B1/pl unknown
- 1976-12-18 PL PL1976209361A patent/PL111422B1/pl unknown
- 1976-12-18 PL PL1976201603A patent/PL103556B1/pl unknown
-
1977
- 1977-09-23 SU SU772524306A patent/SU733516A3/ru active
- 1977-09-23 SU SU772524307A patent/SU652894A3/ru active
- 1977-11-15 ES ES464136A patent/ES464136A1/es not_active Expired
- 1977-11-15 ES ES464162A patent/ES464162A1/es not_active Expired
-
1978
- 1978-07-12 SU SU782633660A patent/SU784776A3/ru active
-
1980
- 1980-05-02 PH PH23979A patent/PH16310A/en unknown
- 1980-11-05 US US06/204,226 patent/US4332802A/en not_active Expired - Lifetime
- 1980-11-13 CH CH843880A patent/CH625243A5/de not_active IP Right Cessation
-
1981
- 1981-10-28 CH CH689681A patent/CH631983A5/de not_active IP Right Cessation
-
1982
- 1982-05-31 YU YU1152/82A patent/YU40078B/xx unknown
-
1983
- 1983-09-01 SG SG554/83A patent/SG55483G/en unknown
-
1984
- 1984-02-16 HK HK129/84A patent/HK12984A/xx unknown
-
1985
- 1985-12-30 MY MY78/85A patent/MY8500078A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL103556B1 (pl) | Sposob wytwarzania nowych pochodnych chinazolonu | |
| US3585198A (en) | Homopyrimidazole derivatives,process for the preparation thereof and pharmaceutical compositions containing same | |
| PT78106B (en) | Process for preparing (2-oxo-1,2,3,5-tetra-hydroymidazo<2,1-b> quinazolinyl)oxyalkylamides | |
| JPH0210821B2 (pl) | ||
| US2924603A (en) | Aralkylbenzmorphan derivatives | |
| JPS5877867A (ja) | ピリダジンのアミノ誘導体、その製造法およびそれを有効成分とする中枢神経系賦活剤 | |
| HU182570B (en) | Process for producing quinoline-3-carboxylic acids | |
| WO1990012574A1 (en) | Dopamine agonist compounds | |
| BG107513A (bg) | Кумаринови производни със сомт инхибираща активност | |
| FR2638161A1 (fr) | Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant | |
| US3968214A (en) | 5-Methylthio-pyrimidine vasodilators | |
| JPS59181273A (ja) | 新規の4′−フラボンカルボン酸、製薬上許容し得るこれら酸の誘導体、その製法及び治療剤としての使用 | |
| US5527796A (en) | Thienothiazine derivatives and their use | |
| US4163785A (en) | Benzothiazepine compounds and compositions | |
| JPH03866B2 (pl) | ||
| JPS6140268A (ja) | イミダゾリン、その付加塩及びその製造方法並びにイミダゾリン又はその付加塩を有効成分とする医薬 | |
| KR880002002B1 (ko) | N-(1,3-디티올란-2-일리덴)아닐린 유도체 및 이의 제조방법 | |
| PL97347B1 (pl) | Sposob wytwarzania nowych 2-fenylohydrazyno-tiazolin lub-tiazyn | |
| FR2473522A1 (fr) | Nouveaux derives substitues de dihydro-2,3 imidazo(1,2-b)pyridazines et les medicaments, utiles notamment comme antidepresseurs, qui en contiennent | |
| US4957909A (en) | Benzobicycloalkane derivatives as anticonvulsant neuroprotective agents | |
| US4220776A (en) | N-(Pyridothienopyrazol)amides | |
| US4122202A (en) | Amino-3H-isobenzofuranones N-substitutes and their therapeutic application | |
| US3862320A (en) | Methods of protection against emesis in mammals by administration of a 3-alkoxy-thianaphthene-2-carboxamide | |
| SU1447283A3 (ru) | Способ получени конденсированных производных @ S-триазина | |
| US4259332A (en) | Novel taurine derivatives |